LY2077855   Click here for help

GtoPdb Ligand ID: 8989

Synonyms: example 66a [WO2009117444] [2]
Compound class: Synthetic organic
Comment: LY2077855 is an inhibitor of fatty acid amide hydrolase (FAAH) activity. It is one of the compounds claimed in patent WO2009117444 'Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors' [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 0
Rotatable bonds 4
Topological polar surface area 63.91
Molecular weight 249.1
XLogP 1.68
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Fc1ccc(cc1)Cc1nnnn1C(=O)N(C)C
Isomeric SMILES Fc1ccc(cc1)Cc1nnnn1C(=O)N(C)C
InChI InChI=1S/C11H12FN5O/c1-16(2)11(18)17-10(13-14-15-17)7-8-3-5-9(12)6-4-8/h3-6H,7H2,1-2H3
InChI Key CKOZVEHVVHCMGD-UHFFFAOYSA-N
References
1. Karbarz MJ, Luo L, Chang L, Tham CS, Palmer JA, Wilson SJ, Wennerholm ML, Brown SM, Scott BP, Apodaca RL et al.. (2009)
Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
Anesth Analg, 108 (1): 316-29. [PMID:19095868]
2. Makriyannis A, Pandarinathan L, Zvonok N, Parkkari T, Chapman L. (2009)
Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors.
Patent number: WO2009117444 A1. Assignee: Northeastern University. Priority date: 17/03/2008. Publication date: 24/09/2009.